GO:0036403 arachidonate 8(S)-lipoxygenase activity

Arachidonate 8(S)-lipoxygenase activity (GO:0036403) is a molecular function that catalyzes the dioxygenation of arachidonic acid at carbon 8 with S stereochemistry, yielding the hydroperoxide (5Z,8S,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate. This activity is one of several lipoxygenase activities that convert polyunsaturated fatty acids into bioactive lipid mediators, and it is defined by both its substrate preference and its regio- and stereospecificity. The enzyme responsible for this activity has been studied primarily in mammalian systems, where it was initially identified in mouse epidermis and later characterized biochemically. Researchers are interested in GO:0036403 because lipoxygenase products participate in a wide range of physiological and pathological processes, including inflammation, cell proliferation, and differentiation. The 8(S)-lipoxygenase reaction is notable for producing a specific hydroperoxide that can be further metabolized to hydroxylated derivatives, which may act as signaling molecules. Unlike some lipoxygenases that are widely expressed, the 8(S)-lipoxygenase activity appears to have a more restricted tissue distribution, making it an attractive target for studying tissue-specific lipid signaling. From a methodological standpoint, studying GO:0036403 requires tools that can measure enzymatic activity, identify the responsible gene product, and manipulate its expression in cellular and animal models. The availability of CRISPR-based genome editing has made it possible to create knockout, point-mutant, and knock-in models to probe the function of the enzyme in a controlled manner. This article provides a comprehensive overview of the definition, mechanism, regulation, disease relevance, and research methods associated with arachidonate 8(S)-lipoxygenase activity, based on the authoritative QuickGO annotation and the published literature.

Arachidonate 8(S)-lipoxygenase activity is defined as the catalysis of the reaction: arachidonate + O2 = (5Z,8S,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate. In simpler terms, it is an enzyme activity that adds two oxygen atoms to arachidonic acid at the 8th carbon, producing a specific hydroperoxide with S stereochemistry at that position. This activity is classified as a molecular_function in the Gene Ontology and is synonymous with 8-lipoxygenase (S-type) and 8(S)-lipoxygenase activity.

Arachidonate 8(S)-lipoxygenase activity is important because it initiates the production of specific lipid mediators that can influence inflammation, cell growth, and differentiation. The enzyme's unique regio- and stereospecificity makes it a valuable model for understanding how lipoxygenases control the type and amount of lipid signals produced in cells. Moreover, because lipoxygenase pathways are implicated in various diseases, including skin disorders and cancer, studying this activity can provide insights into disease mechanisms and potential therapeutic targets.

The following genes and proteins are associated with arachidonate 8(S)-lipoxygenase activity or related lipoxygenase pathways, based on published literature.

The regulation of arachidonate 8(S)-lipoxygenase activity is not fully understood, but it likely involves multiple levels of control. At the transcriptional level, the expression of the gene encoding the enzyme may be regulated by tissue-specific transcription factors and inflammatory stimuli. At the post-translational level, the enzyme's activity can be modulated by calcium, phosphorylation, and interaction with membranes. Additionally, the availability of the substrate arachidonic acid, which is released from membrane phospholipids by phospholipase A2, is a key determinant of activity. Redox conditions and the presence of hydroperoxide scavengers also influence the enzyme's turnover.

Lipoxygenase products, including those from the 8(S)-lipoxygenase pathway, have been implicated in inflammatory skin conditions such as psoriasis and atopic dermatitis. The enzyme's expression in epidermis suggests a role in skin homeostasis and inflammation. However, direct evidence linking GO:0036403 to specific skin diseases remains limited and requires further investigation.

Altered lipoxygenase activity has been observed in various cancers, where lipid mediators can promote cell proliferation and survival. The 8(S)-lipoxygenase product 8(S)-HETE has been reported to stimulate proliferation in some cell types. Nevertheless, the precise contribution of this specific activity to cancer development and progression is not well defined.

Eicosanoids derived from arachidonic acid are known to influence vascular tone and platelet function. While the 8(S)-lipoxygenase pathway is less studied in this context, it may contribute to the overall pool of bioactive lipids that affect cardiovascular health. Further research is needed to establish any causal relationship.

To measure arachidonate 8(S)-lipoxygenase activity directly, researchers can use in vitro assays with purified enzyme or cell lysates, incubating with arachidonic acid and analyzing products by high-performance liquid chromatography (HPLC) or mass spectrometry. These assays allow determination of kinetic parameters and stereospecificity.

Mass spectrometry-based lipidomics enables comprehensive profiling of eicosanoids and related lipids in biological samples. This approach can quantify 8(S)-HETE and other lipoxygenase products, providing insights into pathway activity in cells and tissues.

Quantitative PCR and RNA sequencing can be used to measure the expression of the gene encoding the 8(S)-lipoxygenase and other pathway components. This helps correlate enzyme expression with activity and biological outcomes.

CRISPR-Cas9 genome editing allows the creation of knockout, point-mutant, and knock-in cell lines and animal models to study the function of the 8(S)-lipoxygenase in a physiological context. These models are essential for establishing causality.

Researchers studying arachidonate 8(S)-lipoxygenase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic tools to manipulate the gene of interest and measure the consequences. EDITGENE provides a comprehensive suite of CRISPR-based services to support such investigations, from knockout to knock-in and beyond.

Arachidonate 8(S)-lipoxygenase activity (GO:0036403) is a specific enzymatic function that generates a unique lipid mediator from arachidonic acid. Although its physiological roles are still being elucidated, it represents an important node in lipid signaling networks relevant to inflammation, skin biology, and cancer. Advances in CRISPR genome editing and lipidomics now make it feasible to dissect the function of this activity with unprecedented precision. Continued research will likely clarify its contribution to health and disease and may reveal new therapeutic opportunities.